CLINICAL_TRIALS
trial_result
· 2022-01-03
Clinical Trial Update: Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease [Phase 2]
Summary
Phase 2 trial update for brodalumab in adults with moderate to severe Crohn's disease has been terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Crohn's Disease | Phase 2 | Status: TERMINATED | Results posted: 2022-01-03